• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Carlsmed Inc.

    4/22/26 8:35:06 AM ET
    $CARL
    Medical/Dental Instruments
    Health Care
    Get the next $CARL alert in real time by email
    DEFA14A 1 carl_defa_14a_naa_2026.htm DEFA14A DEFA14A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a) of

    the Securities Exchange Act of 1934

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ☐

    Check the appropriate box:

     

    ☐

    Preliminary Proxy Statement

     

     

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

     

    ☐

    Definitive Proxy Statement

     

     

    ☒

    Definitive Additional Materials

     

     

    ☐

    Soliciting Material under §240.14a-12

     

    Carlsmed, Inc.

    (Name of Registrant as Specified In Its Charter)

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check the appropriate box):

     

    ☒

    No fee required.

     

     

    ☐

    Fee paid previously with preliminary materials.

     

     

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     


     

     

    img54671120_0.jpg

    Your Vote Counts! CARLSMED, INC. 2026 Annual Meeting Vote by June 2, 2026 11:59 PM ET CARLSMED, INC. 1800 ASTON AVENUE, SUITE 100 CARLSBAD, CA 92008 ATTN: CORPORATE SECRETARY V91113-P44852 You invested in CARLSMED, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on June 3, 2026. Get informed before you vote We encourage you to access and review the proxy materials before voting. View the Notice of Annual Meeting of Stockholders, Proxy Statement and Annual Report on Form 10-K online at www.ProxyVote.com OR you can receive a free paper or email copy of the material(s) by requesting prior to May 20, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Point your camera here and vote without entering a control number Vote in Person at the Meeting* June 3, 2026 8:00 A.M. Pacific Time The Offices of Morrison & Foerster LLP 12531 High Bluff Drive Suite 200 San Diego, CA 92130 *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

     


     

     

    img54671120_1.jpg

    Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming 2026 Annual Meeting of Stockholders. Please follow the instructions on the reverse side to vote these important matters. Voting Items Board Recommends 1. To elect two directors to serve as Class I directors for a three-year term to expire at the 2029 annual meeting of stockholders Nominees: 01) Niall Casey 02) Philip Young For 2. To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 For NOTE: Such other business as may properly come before the meeting or any adjournment thereof will be voted on by the proxy holders in their discretion. Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V91114-P44852.

     


    Get the next $CARL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CARL

    DatePrice TargetRatingAnalyst
    8/18/2025$19.00Buy
    Goldman
    8/18/2025$18.00Overweight
    Piper Sandler
    8/18/2025$18.00Buy
    Truist
    8/18/2025$21.00Buy
    BTIG Research
    8/18/2025$16.00Buy
    BofA Securities
    More analyst ratings

    $CARL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, President Cordonnier Michael exercised 391,686 shares at a strike of $0.68 and sold $2,629,889 worth of shares (197,855 units at $13.29), increasing direct ownership by 14% to 1,550,477 units (SEC Form 4)

    4 - CARLSMED, INC. (0001794546) (Issuer)

    3/4/26 4:05:03 PM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    Chief Commercial Officer Durall William Scott was granted 44,977 shares (SEC Form 4)

    4 - CARLSMED, INC. (0001794546) (Issuer)

    1/30/26 5:24:27 PM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    Chief IP Officer Casey Niall was granted 44,977 shares, increasing direct ownership by 5% to 982,562 units (SEC Form 4)

    4 - CARLSMED, INC. (0001794546) (Issuer)

    1/30/26 5:23:14 PM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    $CARL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026

    CARLSBAD, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its first quarter 2026 financial results after market close on Tuesday, May 5, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time. Conference Call Information To participate in this event, dial in approximately 5 to 10 minutes before the start of the conference call. Event Date: Tuesday, May 5, 2026Time: 1:30 PM Pacific Time Participant Registration: https://register-conf.media-server.com/register/BI34a01ff77922411f8b9d41f912e4159b

    4/14/26 8:00:00 AM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference

    CARLSBAD, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 25th Annual Needham Virtual Conference on April 13, 2026 at 11:45 AM ET. A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/cCMfZsH5ZqrwSNTwfC9JDv/RczDxtnmshQKpi2ivHQcH3 About Carlsmed, Inc. Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and bey

    4/1/26 4:01:00 PM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth quarter revenue of $15.2 million; 61% growth YoY  Full year revenue of $50.5 million; 86% growth YoY  CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025.  "We delivered another very strong quarter with 61% revenue growth year-over-year, gross margin expansion to 76.5%, and reduction of our lead times to within six business days. These achievements demonstrate our momentum and the speed at which we are scaling while maintaining our culture o

    2/25/26 4:01:00 PM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    $CARL
    SEC Filings

    View All

    SEC Form DEFA14A filed by Carlsmed Inc.

    DEFA14A - CARLSMED, INC. (0001794546) (Filer)

    4/22/26 8:35:06 AM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    SEC Form DEF 14A filed by Carlsmed Inc.

    DEF 14A - CARLSMED, INC. (0001794546) (Filer)

    4/22/26 8:30:14 AM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by Carlsmed Inc.

    S-8 - CARLSMED, INC. (0001794546) (Filer)

    2/25/26 4:15:33 PM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    $CARL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Carlsmed with a new price target

    Goldman initiated coverage of Carlsmed with a rating of Buy and set a new price target of $19.00

    8/18/25 9:56:23 AM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    Piper Sandler initiated coverage on Carlsmed with a new price target

    Piper Sandler initiated coverage of Carlsmed with a rating of Overweight and set a new price target of $18.00

    8/18/25 9:55:24 AM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    Truist initiated coverage on Carlsmed with a new price target

    Truist initiated coverage of Carlsmed with a rating of Buy and set a new price target of $18.00

    8/18/25 8:55:58 AM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    $CARL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner B Capital Group Management, L.P. converted options into 6,988,430 shares and bought $19,999,995 worth of shares (1,333,333 units at $15.00) (SEC Form 4)

    4 - CARLSMED, INC. (0001794546) (Issuer)

    7/24/25 8:51:14 PM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    Director Sidow Kevin was granted 17,333 shares, converted options into 28,900 shares and bought $199,995 worth of shares (13,333 units at $15.00) (SEC Form 4)

    4 - CARLSMED, INC. (0001794546) (Issuer)

    7/24/25 8:32:18 PM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    Director Mittendorff Robert Ii converted options into 6,988,430 shares and bought $19,999,995 worth of shares (1,333,333 units at $15.00) (SEC Form 4)

    4 - CARLSMED, INC. (0001794546) (Issuer)

    7/24/25 8:31:12 PM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    $CARL
    Financials

    Live finance-specific insights

    View All

    Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026

    CARLSBAD, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its first quarter 2026 financial results after market close on Tuesday, May 5, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time. Conference Call Information To participate in this event, dial in approximately 5 to 10 minutes before the start of the conference call. Event Date: Tuesday, May 5, 2026Time: 1:30 PM Pacific Time Participant Registration: https://register-conf.media-server.com/register/BI34a01ff77922411f8b9d41f912e4159b

    4/14/26 8:00:00 AM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth quarter revenue of $15.2 million; 61% growth YoY  Full year revenue of $50.5 million; 86% growth YoY  CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025.  "We delivered another very strong quarter with 61% revenue growth year-over-year, gross margin expansion to 76.5%, and reduction of our lead times to within six business days. These achievements demonstrate our momentum and the speed at which we are scaling while maintaining our culture o

    2/25/26 4:01:00 PM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    CARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth quarter and full year 2025 financial results after market close on Wednesday, February 25, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time. Conference Call Information To participate in this event, dial in approximately 5 to 10 minutes before the start of the conference call. Event Date: Wednesday, February 25, 2026Time: 1:30 PM Pacific Time Participant Registration: https://register-conf.media-server.com/register/BIb45

    2/11/26 4:01:00 PM ET
    $CARL
    Medical/Dental Instruments
    Health Care

    $CARL
    Leadership Updates

    Live Leadership Updates

    View All

    Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary

    CARLSBAD, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ: CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the appointment of Jenifer Kamocsay as Chief Legal Officer and Secretary, effective immediately. Ms. Kamocsay will serve as legal counsel for the Company and oversee compliance and corporate governance. Ms. Kamocsay brings more than two decades of corporate legal experience as in-house counsel across life science and technology sectors at Akoya Biosicences, Rubius Therapeutics, Inc. and Progress Software Corporation. "We are pleased to welcome Jennifer to the Carlsmed

    9/29/25 9:00:50 AM ET
    $CARL
    Medical/Dental Instruments
    Health Care